Venture Medical
Venture Medical is a U.S. specialty distributor and software provider serving advanced wound care clinics, post-acute providers, and mobile wound care operators with broad product formularies and its proprietary Venture OneView practice management platform.
- Company typePrivate
- Founded2009
- HeadquartersMissoula, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Venture Medical does
Venture Medical, LLC is a Missoula, Montana-based specialty distributor and software provider serving the advanced wound care market in the United States. Founded in 2009 and operating as a private LLC with 51–100 employees, the company combines physical product distribution with a proprietary practice management and workflow platform. Its principal software asset is Venture OneView, which integrates ordering, documentation, billing, and reporting for wound care providers; the January 2025 release of OneView 2.0 added AI-assisted documentation review alongside broader workflow modules.
The company's distribution business covers a broad advanced wound care formulary spanning cellular and tissue-based products, negative pressure wound therapy (NPWT), imaging and analysis tools, and consumable supplies. Distribution relationships include manufacturers such as BioStem and Cork Medical, NPWT providers such as Sanuwave, regenerative tissue players including ProgenaCare (whose assets Venture Medical acquired in June 2025), and computer-vision wound imaging through Swift Medical and MIMOSA. The acquisition of ProgenaCare Global's assets added the ProgenaMatrix keratin-based wound matrix to the in-house product portfolio, signaling a vertical move from pure distribution toward owned product commercialization.
Venture Medical's commercial model is dual: it generates revenue through product sales (and increasingly owned-product margin from ProgenaMatrix) to advanced therapy clinics, post-acute care providers, and mobile wound care operators, while bundling Venture OneView to drive stickiness and capture workflow-level value. The firm is actively engaged on regulatory policy, notably advocating against the CY 2026 Medicare Physician Fee Schedule final rule's $127 cellular and tissue-based products reimbursement rate. Geographic footprint appears U.S.-wide via distribution and a field sales organization, anchored by the Montana headquarters.
Venture Medical firmographics
Firmographics- Name
- Venture Medical
- Legal name
- Venture Medical, LLC
- Website
- https://venturemedical1.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Venture Medical is a U.S. specialty distributor and software provider serving advanced wound care clinics, post-acute providers, and mobile wound care operators with broad product formularies and its proprietary Venture OneView practice management platform.
- Ownership category
- akta.pro rank
Venture Medical industry classification
Industry- Product category
- Wound Care Products Distribution
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Wound Care & Ulcer Management (HLAKACAN)
- akta.pro secondary industry
- Wound Care & Diabetic Foot Infection (HLAKAGAK)
Keywords
Where Venture Medical is headquartered
LocationHeadquarters
- HQ city
- Missoula
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Venture Medical business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Marketing or Sales, Operations, Technology or R&D, Infrastructure
Revenue model
- Wound Care Product Sales: Venture Medical distributes a complete formulary of advanced wound care products including skin substitutes, diagnostics, treatments, and kits. Products are sourced from multiple manufacturers and sold to wound care providers. The company also handles order management and reimbursement support through its software platform.
- Software Subscriptions / Platform Services: Venture OneView™ software platform is provided to wound care practices for practice management, revenue cycle management, and documentation. The platform is offered as part of the service offering to support product distribution and provider operations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Product formulary with stable pricing and 90% reimbursement rate |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Venture Medical product offering
Product offeringCore offering
Venture Medical distributes a complete formulary of advanced wound care products (skin substitutes, diagnostics, treatments, and kits) sourced from multiple manufacturers, and operates Venture OneView, its proprietary wound care practice management platform with AI-powered documentation, patient tracking, inventory management, and revenue cycle management. The company serves wound care providers in the United States through a dedicated Relationship Manager team that combines product distribution with operational and reimbursement support.
Product overview
Venture Medical is a leading distributor and commercializer of advanced wound care products and a developer of proprietary wound care software. The company was founded in 2009 and is headquartered in Missoula, Montana. Its product portfolio spans five categories: proprietary software (Venture OneView practice management platform with AI-powered note review), proprietary kits (Standard Grafting Kit, Standard Of Care Kit, Super Absorbent Standard Of Care Kit), distribution of third-party skin substitutes (Biovance, Grafix PL, OASIS, ProgenaMatrix [acquired via ProgenaCare Global], RevoShield+ Amniotic Barrier, Vendaje AC), distribution of advanced wound treatments (Aurix PRP, Nisus NPWT, UltraMIST, XSONX), and distribution of wound care software and diagnostics (DocNow EHR, MIMOSA Pro, Swift Medical). Venture Medical acts as a distributor for products manufactured by third parties — it does not itself manufacture any products. The core value proposition combines a complete formulary of wound care products with operational support software and relationship management services.
Differentiator
Problem solved
Functional benefit
Brands
- Venture OneView: Wound care software platform for patient tracking, product orders, reimbursement status, and revenue cycle management.
Products and services
- Venture OneView Venture Medical's proprietary cloud-based wound care practice management and revenue cycle management platform. It provides patient tracking, product ordering, reimbursement status monitoring, AI-powered instant clinical note review, QR scan inventory management, and IVR submission tracking, available on both mobile and desktop. Targeted at wound care provider practices.
- ProgenaMatrix The first and only human keratin matrix (HKM) for wound care. An all-natural, hydrated, non-cellular biomaterial composed of native human keratin proteins with two-week dwell time and stable room temperature storage. Acquired via ProgenaCare Global asset acquisition and distributed exclusively through Venture Medical. Targeted at advanced wound care providers treating complex and chronic wounds.
- Swift Medical AI-powered wound care management platform that uses computer vision to capture, measure, and assess wound images for tracking healing progress and clinical documentation. Distributed through Venture Medical's formulary. Targeted at wound care clinicians and practices adopting digital wound assessment.
- Aurix PRP Platelet-rich plasma (PRP) therapy system for wound healing that leverages the patient's own biological material to accelerate tissue repair. Distributed through Venture Medical's formulary. Targeted at advanced wound care providers.
- Nisus NPWT Negative Pressure Wound Therapy (NPWT) system for promoting wound healing through controlled suction and vacuum-assisted closure. Distributed through Venture Medical's formulary. Targeted at advanced wound care providers.
- UltraMIST Acoustic wave therapy system for wound bed preparation using low-frequency ultrasound to support debridement and promote healing. Distributed through Venture Medical's formulary. Targeted at advanced wound care providers.
- XSONX Ultrasonic debridement device for wound bed preparation, enabling precise tissue removal to optimize conditions for advanced wound therapies. Distributed through Venture Medical's formulary. Targeted at advanced wound care providers.
- MIMOSA Pro Advanced wound imaging and diagnostic device for assessing wound characteristics and supporting clinical decision-making. Distributed through Venture Medical's formulary. Targeted at wound care providers adopting digital diagnostics.
- DocNow EHR Electronic Health Record (EHR) system integrated into the Venture Medical portfolio for wound care clinical documentation and practice management. Targeted at wound care practices seeking EHR integration alongside the Venture OneView platform.
- Biovance Decellularized, dehydrated human amniotic membrane (DDHAM) skin substitute derived from the placenta of a healthy, full-term pregnancy, used for advanced wound care. Distributed through Venture Medical's formulary. Targeted at advanced wound care providers treating chronic and complex wounds.
- Grafix PL Placental-based skin substitute product with minimal manipulation to maximize retained biological components for wound healing applications. Distributed through Venture Medical's formulary. Targeted at advanced wound care providers.
- OASIS Single layer porcine small intestinal submucosa (SIS) extracellular matrix scaffold skin substitute indicated for managing a wide range of acute and chronic wounds, with 24-month shelf life at room temperature. Distributed through Venture Medical's formulary. Targeted at advanced wound care providers.
- RevoShield+ Amniotic Barrier Amniotic barrier membrane product for wound protection and healing, sourced from human amniotic tissue. Distributed through Venture Medical's formulary. Targeted at advanced wound care providers.
- Vendaje AC Acellular dermal matrix skin substitute product for advanced wound care applications. Distributed through Venture Medical's formulary. Targeted at advanced wound care providers.
- Standard Grafting Kit Proprietary wound care grafting kit for skin substitute application procedures, designed for use in advanced wound therapy workflows. Targeted at wound care providers performing skin substitute grafting procedures.
- Standard Of Care Kit Proprietary wound care kit bundling standard-of-care supplies for wound treatment and skin substitute procedures. Targeted at wound care providers performing advanced wound therapies.
- Super Absorbent Standard Of Care Kit Enhanced wound care kit with super absorbent components for high-exudate wound management, used in conjunction with advanced wound therapies. Targeted at wound care providers managing high-exudate wounds.
Quantifiable outcome
- 90% reimbursement rate
- +2 more outcomes
Companies that use Venture Medical
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles2 records
Venture Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature5 records
Venture Medical partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- BioStem TechnologiescoreBioStem Technologies partnered with Venture Medical to distribute Vendaje AC® amniotic barrier wound care product. BioStem CEO Jason Matuszewski noted Venture Medical's dedication to wound care, customer relationships, and commitment to advanced technologies makes them an ideal partner for distributing cutting-edge wound care products to a wider audience.
- ProgenaCare GlobalcoreVenture Medical acquired select ProgenaCare Global assets including ProgenaMatrix® human keratin matrix. ProgenaCare Global CEO Howard Walthall described Venture as a great partner for manufacturers of cutting-edge wound care products. ProgenaMatrix is the first and only human keratin matrix for wound care, distributed exclusively through Venture Medical.
- Aurix SystemsminorAurix PRP (Platelet-Rich Plasma) treatment system is distributed through Venture Medical's product formulary. Venture Medical highlights Aurix PRP as a treatment option that leverages the patient's own biology for healing.
- Cork Medical (Nisus NPWT)minorNisus Negative Pressure Wound Therapy (NPWT) system from Cork Medical is distributed through Venture Medical's product formulary as a treatment modality.
- Sanuwave (UltraMIST)minorUltraMIST treatment system from Sanuwave is distributed through Venture Medical's product formulary. UltraMIST uses acoustic energy for wound bed preparation.
- XSONXminorXSONX treatment device is distributed through Venture Medical's product formulary as a wound care treatment modality.
Scale indicators3 records
Recent moves5 records
Expansion highlights6 records
Venture Medical competitors and assessment
Company assessmentBroad incumbents
- Coloplast: Global medical device manufacturer with a major wound and skin care business (Biatain, Triadema dressings, skin substitutes). Larger established player offering overlapping wound care products as part of a broader portfolio spanning ostomy, continence, and interventional urology.
- McKesson: Largest US pharmaceutical and medical supply distributor with extensive medical-surgical distribution to hospitals, physician offices, and post-acute providers. Indirect competitor offering broader scale, deeper manufacturer relationships, and bundled wound care product access.
- Henry Schein: Large US distributor of medical, dental, and animal health products to office-based healthcare providers. Indirect competitor in the medical-surgical and wound care supply space with deep provider relationships and bundled practice solutions.
- Cardinal Health: Major US medical distributor and healthcare services company serving hospitals, ambulatory surgery centers, and physician offices with medical-surgical supplies. Competes indirectly through scale advantages, manufacturer negotiation power, and integrated supply chain offerings.
- Medline Industries: Largest privately held medical supply manufacturer and distributor in the US, with extensive wound care product lines sold to hospitals, nursing homes, and physician offices. Major scale competitor with both manufacturing and distribution across overlapping wound care categories.
- ConvaTec: Global medical products company with a significant Advanced Wound Care business (Aquacel, DuoDERM, InnovaMatrix). Established incumbent selling wound care dressings and skin substitutes to overlapping provider customers as part of a wider portfolio including ostomy and continence care.
- Smith+Nephew: Global medical device company with a substantial Advanced Wound Management division (PICO NPWT, ACTICOAT, skin substitutes). Competes with Venture Medical across multiple product categories including NPWT (Nisus) and skin substitutes as part of a much broader orthopedic and wound care portfolio.
Direct peers
- MiMedx: Regenerative medicine company manufacturing and distributing placental-based skin substitutes (EpiFix, AmnioFix) for wound care. Directly competes with Venture Medical's distributed skin substitute portfolio (Biovance, Grafix PL, OASIS) for the same advanced wound care providers.
- Organogenesis: Leading regenerative medicine manufacturer of skin substitutes (Apligraf, Dermagraft, PuraPly) for wound care. Competes head-to-head with Venture Medical's skin substitute formulary and sells through overlapping provider channels including wound care clinics and post-acute facilities.
- Advanced Tissue: Specialty wound care product distributor serving providers and patients across the US, offering skin substitutes, dressings, and related wound care supplies. Closest direct competitor in wound care specialty distribution with overlapping formulary and provider customer base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Venture Medical social profiles
Digital presenceVenture Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Venture Medical leadership team
Management profileNumber of profiles
Profiles10 records
Venture Medical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Venture Medical M&A and investment
M&A and investmentM&A1 record
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Venture Medical
What does Venture Medical do?
Venture Medical distributes a complete formulary of advanced wound care products (skin substitutes, diagnostics, treatments, and kits) sourced from multiple manufacturers, and operates Venture OneView, its proprietary wound care practice management platform with AI-powered documentation, patient tracking, inventory management, and revenue cycle management. The company serves wound care providers in the United States through a dedicated Relationship Manager team that combines product distribution with operational and reimbursement support.
Is Venture Medical a public or private company?
Venture Medical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Venture Medical founded?
Venture Medical was founded in 2009. It employs 51 to 100 people.
Where is Venture Medical based?
Venture Medical is headquartered in Missoula, United States, in the North America region.
How does Venture Medical make money?
Two revenue lines are on record. Wound Care Product Sales are the primary driver. The others are software Subscriptions / Platform Services.
Who are Venture Medical's main competitors?
Broad incumbents on record are Coloplast, McKesson, Henry Schein, Cardinal Health, Medline Industries, ConvaTec and Smith+Nephew. Direct peers are MiMedx, Organogenesis and Advanced Tissue.
Does Venture Medical have an API?
No public API is recorded for Venture Medical.
What industry is Venture Medical in?
Venture Medical's product category is Wound Care Products Distribution. Its primary akta.pro industry code is HLAKACAN, Wound Care & Ulcer Management, with a secondary code of HLAKAGAK, Wound Care & Diabetic Foot Infection. Its SIC code is 5047.